6 research outputs found

    Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    No full text
    International audienc

    Summary and Review of Investigations Relating to Reading July 1, 1965 to June 30, 1966

    No full text

    Annual Selected Bibliography

    No full text
    corecore